(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.

The three most active and biggest winners today are Arcturus Therapeutics, Exicure, and ToughBuilt Industries.

Rank Financial Asset Price Change Updated (EST)
1 Arcturus Therapeutics (ARCT) 58.25 68.06% 2021-08-03 15:11:28
2 Exicure (XCUR) 1.81 34.07% 2021-08-03 00:17:05
3 ToughBuilt Industries (TBLTW) 0.22 12.76% 2021-08-02 20:42:06
4 Moderna (MRNA) 386.51 11.51% 2021-08-03 15:12:21
5 Vaxart (VXRT) 7.99 11.13% 2021-08-02 23:42:05
6 Gartner (IT) 293.67 10.83% 2021-08-03 15:15:39
7 NeuroMetrix (NURO) 14.54 10.82% 2021-08-03 15:35:27
8 Scholar Rock Holding Corporation (SRRK) 34.34 9.89% 2021-08-02 19:31:30
9 Chesapeake Granite Wash Trust (CHKR) 0.65 8.33% 2021-08-03 07:23:10
10 Pioneer Natural Resources (PXD) 153.51 7.84% 2021-08-03 15:16:28

The three most active and biggest losers today are NASDAQ TEST STOCK, Xenetic Biosciences, and Vistas Media Acquisition Company.

Rank Financial Asset Price Change Updated (EST)
1 NASDAQ TEST STOCK (ZWZZT) 10.00 -44.2% 2021-08-03 01:11:04
2 Xenetic Biosciences (XBIO) 3.52 -21.08% 2021-08-03 15:13:16
3 Vistas Media Acquisition Company (VMACW) 1.02 -13.56% 2021-08-02 23:11:23
4 NetEase (NTES) 93.06 -11.41% 2021-08-03 15:09:53
5 Tuscan Holdings Corp. II (THCAW) 1.01 -10.62% 2021-08-02 21:09:05
6 China Green Agriculture (CGA) 8.78 -10.32% 2021-08-03 07:13:05
7 Clorox Company (CLX) 164.06 -9.46% 2021-08-03 16:14:31
8 Nikola (NKLA) 10.21 -8.68% 2021-08-03 15:12:26
9 DouYu (DOYU) 3.75 -8.54% 2021-08-03 15:11:55
10 Greenhill & Co. (GHL) 14.65 -8.27% 2021-08-03 15:45:24

Most Active Winners today

1. Arcturus Therapeutics (ARCT) – 68.06%

NASDAQ Composite ended the session with Arcturus Therapeutics jumping 68.06% to $58.25 on Tuesday while NASDAQ Composite rose 0.55% to $14,761.30.

Volume

Today’s last reported volume for Arcturus Therapeutics is 9720840 which is 1852.13% above its average volume of 497960.

Arcturus Therapeutics’s last close was $31.31, 75.86% under its 52-week high of $129.71.

Arcturus Therapeutics’s Sales

Arcturus Therapeutics’s sales growth is a negative 34.5% for the current quarter and 321.3% for the next. The company’s growth estimates for the ongoing quarter and the next is a negative 289.1% and a negative 129.3%, respectively.

Arcturus Therapeutics’s Revenue

Year-on-year quarterly revenue growth declined by 24.6%, now sitting on 9.54M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Arcturus Therapeutics’s stock is considered to be overbought (>=80).

Arcturus Therapeutics’s Stock Yearly Top and Bottom Value

Arcturus Therapeutics’s stock is valued at $58.25 at 17:32 EST, way under its 52-week high of $129.71 and way higher than its 52-week low of $24.87.

Arcturus Therapeutics’s Moving Average

Arcturus Therapeutics’s value is way above its 50-day moving average of $32.51 and way higher than its 200-day moving average of $43.28.

More news about Arcturus Therapeutics.

2. Exicure (XCUR) – 34.07%

NASDAQ Composite ended the session with Exicure jumping 34.07% to $1.81 on Tuesday, following the last session’s upward trend. NASDAQ Composite jumped 0.55% to $14,761.30, following the last session’s upward trend on what was a somewhat positive trend trading session today.

Volume

Today’s last reported volume for Exicure is 106840000 which is 24885.7% above its average volume of 427606.

Exicure’s last close was $1.81, 36.04% under its 52-week high of $2.83.

The company’s growth estimates for the current quarter and the next is a negative 180% and a negative 40%, respectively.

Exicure’s Revenue

Year-on-year quarterly revenue growth declined by 89.1%, now sitting on 8.43M for the twelve trailing months.

Exicure’s Stock Yearly Top and Bottom Value

Exicure’s stock is valued at $1.81 at 17:32 EST, way under its 52-week high of $2.83 and way higher than its 52-week low of $1.34.

Exicure’s Moving Average

Exicure’s worth is way higher than its 50-day moving average of $1.50 and below its 200-day moving average of $1.92.

Previous days news about Exicure

Ever-glory stock rockets to pace premarket gainers, exicure leads most-actives list. According to MarketWatch on Monday, 2 August, "The most active stock in the premarket is Exicure Inc.’s , which ran up 36.3% on 16.0 million shares after Ipsen said it will make an upfront cash payment of $20 million to Exicure as part of an exclusive collaboration to research, develop and commercialize potential treatments for Huntington’s disease and Angelman syndrome. "

More news about Exicure.

3. ToughBuilt Industries (TBLTW) – 12.76%

NASDAQ Composite ended the session with ToughBuilt Industries jumping 12.76% to $0.22 on Tuesday, after two sequential sessions in a row of gains. NASDAQ Composite rose 0.55% to $14,761.30, following the last session’s upward trend on what was a somewhat up trend trading session today.

Volume

Today’s last reported volume for ToughBuilt Industries is 12915 which is 62.16% below its average volume of 34134.

ToughBuilt Industries’s last close was $0.22, 76.18% under its 52-week high of $0.91.

ToughBuilt Industries’s Stock Yearly Top and Bottom Value

ToughBuilt Industries’s stock is valued at $0.22 at 17:32 EST, way under its 52-week high of $0.91 and way higher than its 52-week low of $0.02.

ToughBuilt Industries’s Moving Average

ToughBuilt Industries’s worth is under its 50-day moving average of $0.22 and way below its 200-day moving average of $0.27.

More news about ToughBuilt Industries.

4. Moderna (MRNA) – 11.51%

NASDAQ Composite ended the session with Moderna jumping 11.51% to $386.51 on Tuesday, following the last session’s upward trend. NASDAQ Composite rose 0.55% to $14,761.30, following the last session’s upward trend on what was a somewhat up trend exchanging session today.

Volume

Today’s last reported volume for Moderna is 20217400 which is 56.33% above its average volume of 12932900.

Moderna’s last close was $353.60, 2.32% under its 52-week high of $362.00.

Moderna’s Sales

Moderna’s sales growth is 6347.1% for the ongoing quarter and 7189.7% for the next. The company’s growth estimates for the ongoing quarter and the next is 2048.4% and 1439%, respectively.

Moderna’s Revenue

Year-on-year quarterly revenue growth grew by 24112.5%, now sitting on 2.73B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Moderna’s stock is considered to be oversold (<=20).

Moderna’s Stock Yearly Top and Bottom Value

Moderna’s stock is valued at $386.51 at 17:32 EST, higher than its 52-week high of $362.00.

Moderna’s Moving Average

Moderna’s worth is way above its 50-day moving average of $257.86 and way higher than its 200-day moving average of $183.99.

Previous days news about Moderna

Pfizer, Moderna increase EU vaccine pricing in latest deals: FT. According to Bloomberg Quint on Sunday, 1 August, "Pfizer Inc. and Moderna Inc. have increased the prices of their Covid-19 vaccines in the latest supply contracts with the European Union, the Financial Times reported."

Pfizer, Moderna hike prices of vaccine shots supplied to eu: report. According to Benzinga on Sunday, 1 August, "Late-stage study of the mRNA vaccine Pfizer is co-developing with BioNTech SE (NASDAQ: BNTX) showed vaccine efficacy of 95%, while a similar class of vaccine developed by Moderna boasted vaccine efficacy of 94.1%.", "Pfizer and Moderna have managed to expand the age range oftheir vaccines to include adolescents and they are also running trials on pediatric population. "

More news about Moderna.

5. Vaxart (VXRT) – 11.13%

NASDAQ Composite ended the session with Vaxart rising 11.13% to $7.99 on Tuesday, following the last session’s upward trend. NASDAQ Composite jumped 0.55% to $14,761.30, following the last session’s upward trend on what was a somewhat positive trend trading session today.

Volume

Today’s last reported volume for Vaxart is 24986900 which is 95.24% above its average volume of 12798300.

Vaxart’s last close was $7.99, 67.91% under its 52-week high of $24.90.

The company’s growth estimates for the ongoing quarter and the next is a negative 16.7% and a negative 87.5%, respectively.

Vaxart’s Revenue

Year-on-year quarterly revenue growth declined by 82.6%, now sitting on 1.65M for the twelve trailing months.

Vaxart’s Stock Yearly Top and Bottom Value

Vaxart’s stock is valued at $7.99 at 17:32 EST, way below its 52-week high of $24.90 and way above its 52-week low of $3.50.

Vaxart’s Moving Average

Vaxart’s value is above its 50-day moving average of $7.75 and higher than its 200-day moving average of $7.41.

More news about Vaxart.

6. Gartner (IT) – 10.83%

NYSE Composite ended the session with Gartner rising 10.83% to $293.67 on Tuesday while NYSE Composite jumped 0.83% to $16,713.46.

Volume

Today’s last reported volume for Gartner is 1431040 which is 113.71% above its average volume of 669615.

Gartner’s last close was $264.73, 9.16% below its 52-week high of $291.41.

Gartner’s Sales

Gartner’s sales growth is 14.8% for the ongoing quarter and 10.5% for the next. The company’s growth estimates for the present quarter and the next is 44.2% and 30.8%, respectively.

Gartner’s Revenue

Year-on-year quarterly revenue growth grew by 8.4%, now sitting on 4.18B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Gartner’s stock is considered to be oversold (<=20).

Gartner’s Stock Yearly Top and Bottom Value

Gartner’s stock is valued at $293.67 at 17:32 EST, above its 52-week high of $291.41.

Gartner’s Moving Average

Gartner’s worth is way above its 50-day moving average of $249.66 and way above its 200-day moving average of $208.14.

More news about Gartner.

7. NeuroMetrix (NURO) – 10.82%

NASDAQ Composite ended the session with NeuroMetrix jumping 10.82% to $14.54 on Tuesday while NASDAQ Composite jumped 0.55% to $14,761.30.

Volume

Today’s last reported volume for NeuroMetrix is 5598170 which is 27.51% below its average volume of 7722650.

NeuroMetrix’s last close was $14.90, 61.55% below its 52-week high of $38.75.

NeuroMetrix’s Revenue

Year-on-year quarterly revenue growth declined by 0.8%, now sitting on 7.36M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

NeuroMetrix’s stock is considered to be overbought (>=80).

NeuroMetrix’s Stock Yearly Top and Bottom Value

NeuroMetrix’s stock is valued at $14.54 at 17:32 EST, way below its 52-week high of $38.75 and way higher than its 52-week low of $1.39.

NeuroMetrix’s Moving Average

NeuroMetrix’s value is way above its 50-day moving average of $7.28 and way higher than its 200-day moving average of $4.45.

More news about NeuroMetrix.

8. Scholar Rock Holding Corporation (SRRK) – 9.89%

NASDAQ Composite ended the session with Scholar Rock Holding Corporation rising 9.89% to $34.34 on Tuesday while NASDAQ Composite jumped 0.55% to $14,761.30.

Volume

Today’s last reported volume for Scholar Rock Holding Corporation is 173064 which is 33.99% below its average volume of 262160.

Scholar Rock Holding Corporation’s last close was $34.34, 50.94% under its 52-week high of $70.00.

Scholar Rock Holding Corporation’s Sales

Scholar Rock Holding Corporation’s sales growth is 33.3% for the present quarter and 71.2% for the next. The company’s growth estimates for the present quarter and the next is a negative 20% and a negative 3.8%, respectively.

Scholar Rock Holding Corporation’s Revenue

Year-on-year quarterly revenue growth declined by 6.4%, now sitting on 15.08M for the twelve trailing months.

Scholar Rock Holding Corporation’s Stock Yearly Top and Bottom Value

Scholar Rock Holding Corporation’s stock is valued at $34.34 at 17:32 EST, way below its 52-week high of $70.00 and way higher than its 52-week low of $11.33.

Scholar Rock Holding Corporation’s Moving Average

Scholar Rock Holding Corporation’s worth is way above its 50-day moving average of $30.59 and way below its 200-day moving average of $40.68.

More news about Scholar Rock Holding Corporation.

9. Chesapeake Granite Wash Trust (CHKR) – 8.33%

NYSE Composite ended the session with Chesapeake Granite Wash Trust rising 8.33% to $0.65 on Tuesday, following the last session’s downward trend. NYSE Composite jumped 0.83% to $16,713.46, after two consecutive sessions in a row of losses, on what was a somewhat positive trend exchanging session today.

Volume

Today’s last reported volume for Chesapeake Granite Wash Trust is 49528 which is 49.36% below its average volume of 97798.

Chesapeake Granite Wash Trust’s last close was $0.60, 33.33% under its 52-week high of $0.90.

Chesapeake Granite Wash Trust’s Revenue

Year-on-year quarterly revenue growth declined by 55.5%, now sitting on 3.83M for the twelve trailing months.

Chesapeake Granite Wash Trust’s Stock Yearly Top and Bottom Value

Chesapeake Granite Wash Trust’s stock is valued at $0.65 at 17:32 EST, way under its 52-week high of $0.90 and way higher than its 52-week low of $0.20.

Chesapeake Granite Wash Trust’s Moving Average

Chesapeake Granite Wash Trust’s value is way higher than its 50-day moving average of $0.59 and way above its 200-day moving average of $0.40.

More news about Chesapeake Granite Wash Trust.

10. Pioneer Natural Resources (PXD) – 7.84%

NYSE Composite ended the session with Pioneer Natural Resources rising 7.84% to $153.51 on Tuesday, following the last session’s downward trend. NYSE Composite rose 0.83% to $16,713.46, after two sequential sessions in a row of losses, on what was a somewhat positive trend exchanging session today.

Volume

Today’s last reported volume for Pioneer Natural Resources is 4150530 which is 61.76% above its average volume of 2565800.

Pioneer Natural Resources’s last close was $145.37, 17.11% under its 52-week high of $175.37.

Pioneer Natural Resources’s Sales

Pioneer Natural Resources’s sales growth is 244.7% for the ongoing quarter and 169.5% for the next. The company’s growth estimates for the present quarter and the next is 881.2% and 2000%, respectively.

Pioneer Natural Resources’s Revenue

Year-on-year quarterly revenue growth grew by 52.4%, now sitting on 8.08B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Pioneer Natural Resources’s stock is considered to be overbought (>=80).

Pioneer Natural Resources’s Stock Yearly Top and Bottom Value

Pioneer Natural Resources’s stock is valued at $153.51 at 17:32 EST, way below its 52-week high of $175.37 and way above its 52-week low of $76.58.

Pioneer Natural Resources’s Moving Average

Pioneer Natural Resources’s worth is under its 50-day moving average of $157.23 and higher than its 200-day moving average of $150.66.

More news about Pioneer Natural Resources.

Most Active Losers Today

1. NASDAQ TEST STOCK (ZWZZT) – -44.2%

NASDAQ Composite ended the session with NASDAQ TEST STOCK sliding 44.2% to $10.00 on Tuesday while NASDAQ Composite rose 0.55% to $14,761.30.

NASDAQ TEST STOCK’s last close was $10.00, 0% under its 52-week high of $10.00.

NASDAQ TEST STOCK’s Stock Yearly Top and Bottom Value

NASDAQ TEST STOCK’s stock is valued at $10.00 at 17:32 EST, below its 52-week low of $10.00.

More news about NASDAQ TEST STOCK.

2. Xenetic Biosciences (XBIO) – -21.08%

NASDAQ Composite ended the session with Xenetic Biosciences falling 21.08% to $3.52 on Tuesday while NASDAQ Composite rose 0.55% to $14,761.30.

Volume

Today’s last reported volume for Xenetic Biosciences is 4537960 which is 47.54% below its average volume of 8649680.

Xenetic Biosciences’s last close was $4.07, 30.43% below its 52-week high of $5.85.

The company’s growth estimates for the present quarter is a negative 6.7% and positive 85% for the next.

Xenetic Biosciences’s Revenue

Year-on-year quarterly revenue growth grew by 786.7%, now sitting on 436.94k for the twelve trailing months.

Xenetic Biosciences’s Stock Yearly Top and Bottom Value

Xenetic Biosciences’s stock is valued at $3.52 at 17:32 EST, way under its 52-week high of $5.85 and way higher than its 52-week low of $0.76.

Xenetic Biosciences’s Moving Average

Xenetic Biosciences’s value is way above its 50-day moving average of $2.29 and way above its 200-day moving average of $2.32.

More news about Xenetic Biosciences.

3. Vistas Media Acquisition Company (VMACW) – -13.56%

NASDAQ Composite ended the session with Vistas Media Acquisition Company dropping 13.56% to $1.02 on Tuesday while NASDAQ Composite jumped 0.55% to $14,761.30.

Vistas Media Acquisition Company’s last close was $1.02, 8.11% below its 52-week high of $1.11.

Vistas Media Acquisition Company’s Stock Yearly Top and Bottom Value

Vistas Media Acquisition Company’s stock is valued at $1.02 at 17:32 EST, below its 52-week high of $1.11 and above its 52-week low of $1.00.

More news about Vistas Media Acquisition Company.

4. NetEase (NTES) – -11.41%

NASDAQ Composite ended the session with NetEase sliding 11.41% to $93.06 on Tuesday while NASDAQ Composite jumped 0.55% to $14,761.30.

Volume

Today’s last reported volume for NetEase is 6601350 which is 163.36% above its average volume of 2506620.

NetEase’s last close was $102.21, 23.91% below its 52-week high of $134.33.

NetEase’s Sales

NetEase’s sales growth is 13.8% for the ongoing quarter and 20.4% for the next. The company’s growth estimates for the ongoing quarter is a negative 21.3% and positive 19.5% for the next.

NetEase’s Revenue

Year-on-year quarterly revenue growth grew by 20.2%, now sitting on 77.12B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

NetEase’s stock is considered to be oversold (<=20).

NetEase’s Stock Yearly Top and Bottom Value

NetEase’s stock is valued at $93.06 at 17:32 EST, way below its 52-week high of $134.33 and way above its 52-week low of $82.50.

NetEase’s Moving Average

NetEase’s worth is way below its 50-day moving average of $108.30 and way under its 200-day moving average of $111.31.

More news about NetEase.

5. Tuscan Holdings Corp. II (THCAW) – -10.62%

NASDAQ Composite ended the session with Tuscan Holdings Corp. II dropping 10.62% to $1.01 on Tuesday while NASDAQ Composite rose 0.55% to $14,761.30.

Tuscan Holdings Corp. II’s last close was $1.01, 11.4% below its 52-week high of $1.14.

Tuscan Holdings Corp. II’s Stock Yearly Top and Bottom Value

Tuscan Holdings Corp. II’s stock is valued at $1.01 at 17:32 EST, way below its 52-week high of $1.14 and above its 52-week low of $0.99.

More news about Tuscan Holdings Corp. II.

6. China Green Agriculture (CGA) – -10.32%

NYSE Composite ended the session with China Green Agriculture sliding 10.32% to $8.78 on Tuesday while NYSE Composite jumped 0.83% to $16,713.46.

Volume

Today’s last reported volume for China Green Agriculture is 36949 which is 43.87% below its average volume of 65828.

China Green Agriculture’s last close was $8.78, 50.48% under its 52-week high of $17.73.

China Green Agriculture’s Revenue

Year-on-year quarterly revenue growth grew by 0.3%, now sitting on 241.6M for the twelve trailing months.

China Green Agriculture’s Stock Yearly Top and Bottom Value

China Green Agriculture’s stock is valued at $8.78 at 17:32 EST, way under its 52-week high of $17.73 and way higher than its 52-week low of $1.77.

China Green Agriculture’s Moving Average

China Green Agriculture’s value is way under its 50-day moving average of $10.07 and below its 200-day moving average of $9.04.

More news about China Green Agriculture.

7. Clorox Company (CLX) – -9.46%

NYSE Composite ended the session with Clorox Company sliding 9.46% to $164.06 on Tuesday, following the last session’s downward trend. NYSE Composite rose 0.83% to $16,713.46, after two successive sessions in a row of losses, on what was a somewhat up trend trading session today.

Volume

Today’s last reported volume for Clorox Company is 9849240 which is 649.15% above its average volume of 1314710.

Clorox Company’s last close was $180.89, 24.59% below its 52-week high of $239.87.

The company’s growth estimates for the present quarter and the next is a negative 43.6% and a negative 20.5%, respectively.

Clorox Company’s Revenue

Year-on-year quarterly revenue growth declined by 0.1%, now sitting on 7.52B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Clorox Company’s stock is considered to be overbought (>=80).

Clorox Company’s Stock Yearly Top and Bottom Value

Clorox Company’s stock is valued at $164.06 at 17:32 EST, way below its 52-week high of $239.87 and above its 52-week low of $159.32.

Clorox Company’s Moving Average

Clorox Company’s worth is below its 50-day moving average of $179.46 and way under its 200-day moving average of $185.99.

More news about Clorox Company.

8. Nikola (NKLA) – -8.68%

NASDAQ Composite ended the session with Nikola falling 8.68% to $10.21 on Tuesday while NASDAQ Composite rose 0.55% to $14,761.30.

Volume

Today’s last reported volume for Nikola is 30100600 which is 163.05% above its average volume of 11443100.

Nikola’s last close was $11.87, 78.24% below its 52-week high of $54.56.

News about Nikola today

Nikola stock rallies after reporting narrower loss than expected. According to today’s article on MarketWatch, "Shares of Nikola Corp. rallied 2.0% in premarket trading Tuesday, after the battery-electric and hydrogen-electric vehicle and components maker reported a narrower-than-expected second-quarter loss. ", "The company said the second-half 2021 objectives it expects to achieve include delivering pre-series Nikola Tre battery-electric vehicles (BEVs) for use on public roads to haul freight, break ground on the first commercial hydrogen station. "

Nikola shares rally after narrower-than-forecast loss. According to today’s article on MarketWatch, "Shares of Nikola Corp. rallied 2.0% in premarket trading Tuesday, after the battery-electric and hydrogen-electric vehicle and components maker reported a narrower-than-expected second-quarter loss. ", "The company said the second-half 2021 objectives it expects to achieve include delivering pre-series Nikola Tre battery-electric vehicles (BEVs) for use on public roads to haul freight, break ground on the first commercial hydrogen station. "

Nikola posts wider adj. loss in Q2. According to today’s article on Business Insider, "In the second half of 2021, the company plans to deliver pre-series Nikola Tre BEVs for use on public roads hauling customer freight, and announce additional fleet testing customers/dealers."

Nikola falls after revising down electric truck deliveries. According to today’s article on Bloomberg Quint, "Shares of Nikola Corp., the pre-production truckmaker whose founder was charged last week with misleading investors, fell after the company lowered its initial vehicle delivery projections and warned of nagging supply chain issues.", "Chief Executive Officer Mark Russell told analysts on a conference call Tuesday the startup is facing "numerous" delays acquiring parts and Kim Brady, the chief financial officer, said Nikola would deliver as few as half as many vehicles as previously forecast."

The company’s growth estimates for the ongoing quarter and the next is a negative 81.2% and a negative 81.2%, respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Nikola’s stock is considered to be overbought (>=80).

Nikola’s Stock Yearly Top and Bottom Value

Nikola’s stock is valued at $10.21 at 17:32 EST, way below its 52-week high of $54.56 and higher than its 52-week low of $9.37.

Nikola’s Moving Average

Nikola’s value is way below its 50-day moving average of $15.53 and way under its 200-day moving average of $15.99.

More news about Nikola.

9. DouYu (DOYU) – -8.54%

NASDAQ Composite ended the session with DouYu sliding 8.54% to $3.75 on Tuesday, following the last session’s upward trend. NASDAQ Composite jumped 0.55% to $14,761.30, following the last session’s upward trend on what was a somewhat up trend trading session today.

Volume

Today’s last reported volume for DouYu is 7557240 which is 56.59% above its average volume of 4826230.

DouYu’s last close was $4.03, 80.38% below its 52-week high of $20.54.

The company’s growth estimates for the ongoing quarter and the next is a negative 131.2% and a negative 150%, respectively.

DouYu’s Revenue

Year-on-year quarterly revenue growth declined by 5.5%, now sitting on 9.48B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

DouYu’s stock is considered to be overbought (>=80).

DouYu’s Stock Yearly Top and Bottom Value

DouYu’s stock is valued at $3.75 at 17:32 EST, way below its 52-week high of $20.54 and higher than its 52-week low of $3.69.

DouYu’s Moving Average

DouYu’s worth is way under its 50-day moving average of $5.90 and way under its 200-day moving average of $10.03.

More news about DouYu.

10. Greenhill & Co. (GHL) – -8.27%

NYSE Composite ended the session with Greenhill & Co. sliding 8.27% to $14.65 on Tuesday while NYSE Composite jumped 0.83% to $16,713.46.

Volume

Today’s last reported volume for Greenhill & Co. is 186032 which is 37.29% above its average volume of 135506.

Greenhill & Co.’s last close was $16.02, 20.26% under its 52-week high of $20.09.

Greenhill & Co.’s Sales

Greenhill & Co.’s sales growth is 51.9% for the current quarter and 42.9% for the next. The company’s growth estimates for the current quarter and the next is 132.9% and 189.8%, respectively.

Greenhill & Co.’s Revenue

Year-on-year quarterly revenue growth grew by 5.5%, now sitting on 299.59M for the twelve trailing months.

Greenhill & Co.’s Stock Yearly Top and Bottom Value

Greenhill & Co.’s stock is valued at $14.65 at 17:32 EST, way under its 52-week high of $20.09 and way higher than its 52-week low of $9.75.

Greenhill & Co.’s Moving Average

Greenhill & Co.’s value is under its 50-day moving average of $15.12 and below its 200-day moving average of $15.77.

More news about Greenhill & Co..

Stay up to date with our winners and losers daily report

LEAVE A REPLY

Please enter your comment!
Please enter your name here